PG Gobbi, ML Ghirardelli, P Avanzini, L Baldini, G Quarta, C Stelitano, C Broglia, C Loni, V Silingardi, E Ascari. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin’s lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Haematologica 2000;85(3):263-268; https://doi.org/10.3324/%x.